AQR Capital Management’s Actuate Therapeutics ACTU Stock Holding History
Bought
Maintained
Sold
Other funds holding ACTU
AQR Capital Management's ACTU Position: Q3 2026 in Review
AQR Capital Management sold out of Actuate Therapeutics (ACTU) in Q3 2026, closing a stake of 127,493 shares — an estimated $195K sold.
AQR Capital Management first reported a position in ACTU in Q1 2026 and held it in 2 quarters. The position peaked at $195K in Q2 2026. 40 funds tracked by Wall St. Rank hold ACTU as of Q3 2026.
- AQR Capital Management reported no remaining Actuate Therapeutics position as of Q3 2026 after selling out during the quarter.
- AQR Capital Management sold 127,493 Actuate Therapeutics shares in Q3 2026, an estimated $195K.
- AQR Capital Management first reported a position in Actuate Therapeutics in Q1 2026 and held it in 2 quarters.
- AQR Capital Management's Actuate Therapeutics position peaked at $195K in Q2 2026.
- 40 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q3 2026.
Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.